Brief: Spectral Medical Says Unit Dialco Medical Granted FDA IDE Authorization To Conduct Trial Of DIMI For Home Hemodialysis Use
23/02/2021 13:06
Feb 23 (Reuters) - Spectral Medical Inc EDT.TO :
* SPECTRAL MEDICAL - UNIT DIALCO MEDICAL GRANTED FDA IDE
AUTHORIZATION TO CONDUCT TRIAL OF DIMI FOR HOME HEMODIALYSIS USE
Source text for Eikon: ID:nGNX4D2QLV
Further company coverage: EDT.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spectral Medical
See all newsBrief: Spectral Medical Provides Update Following In-Person FDA 100-Day Meeting For PMX PMA
Canada's Spectral Medical Q2 revenue falls on lower reagent sales
Brief: Spectral Medical And Vantive Announce Topline 12 Month Follow-Up Results From Spectral’S Tigris Trial
Canada's Spectral Medical Q1 revenue rises 56%, net loss narrows
Spectral Medical Q3 revenue up 34%